Alka Seltzer Plus Maximum Strength Sinus, Allergy And Cough Power Max Gels Capsule, Liquid Filled
NDC Package 0280-0097-01
Package Information
Alka Seltzer Plus Maximum Strength Sinus, Allergy And Cough Power Max Gels (acetaminophen, dextromethorphan hydrobromide , doxylamine succinate, phenylephrine hydrochloride) capsules is uses · temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: · runny nose · sneezing · itching of the nose or throat · itchy, watery eyes· temporarily relieves these symptoms due to a cold: · minor aches and pains · headache · cough · sore throat · nasal congestion · sinus congestion and pressure · temporarily reduces fever. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Bayer Healthcare Llc., this product is identified by NDC 0280-0097 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1297288 - acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule
- RxCUI: 1297288 - acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule
- RxCUI: 1297288 - APAP 325 MG / Dextromethorphan Hydrobromide 10 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Antihistamine - [EPC] (Established Pharmacologic Class)
- Histamine Receptor Antagonists - [MoA] (Mechanism of Action)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 0280 - Bayer Healthcare Llc.
- 0280-0097 - Alka Seltzer Plus Maximum Strength Sinus, Allergy And Cough Power Max Gels
- 0280-0097-01 - 2 BLISTER PACK in 1 CARTON / 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
- 0280-0097 - Alka Seltzer Plus Maximum Strength Sinus, Allergy And Cough Power Max Gels
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0280-0097). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0280-0097-01 identifies a specific commercial package of 2 blister pack in 1 carton / 8 capsule, liquid filled in 1 blister pack of Alka Seltzer Plus Maximum Strength Sinus, Allergy And Cough Power Max Gels, a human over the counter drug labeled by Bayer Healthcare Llc.. This capsule, liquid filled is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide; doxylamine succinate; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bayer Healthcare Llc. on May 25, 2021. The current certification is valid through December 31, 2027.
How is this Bayer Healthcare Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00280009701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.